Urticaria, angioedema and dyspnoea in adjuvant therapy of melanoma with interferon alpha-2b

Acta Derm Venereol. 2010 May;90(3):308-9. doi: 10.2340/00015555-0826.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angioedema / chemically induced*
  • Angioedema / drug therapy
  • Antineoplastic Agents / adverse effects*
  • Chemotherapy, Adjuvant
  • Dimethindene / administration & dosage
  • Drug Hypersensitivity / drug therapy
  • Drug Hypersensitivity / etiology*
  • Dyspnea / chemically induced*
  • Dyspnea / drug therapy
  • Glucocorticoids / administration & dosage
  • Histamine H1 Antagonists / administration & dosage
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Male
  • Melanoma / drug therapy*
  • Methylprednisolone / administration & dosage
  • Middle Aged
  • Recombinant Proteins
  • Skin Neoplasms / drug therapy*
  • Treatment Outcome
  • Urticaria / chemically induced*
  • Urticaria / drug therapy

Substances

  • Antineoplastic Agents
  • Glucocorticoids
  • Histamine H1 Antagonists
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Dimethindene
  • Methylprednisolone